|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Monday, October 31, 2016Memory Cafes help engage people with Alzheimer’s, dementia
Joe Rennie of
Evansville watches as his wife Pat paints a jack o' lantern during a
Memory Cafe at the Alzheimer's Association in Evansville earlier this
month. The cafe is a social engagement group for people with
early-stage dementia and their partners. (Photo: Jason Clark /
Courier & Press)
Tony Payne
knew something was wrong. He was forgetting simple things like his
grandchildren’s names.
Read more »Sunday, October 30, 2016Advanced analysis of brain structure shape may track progression to Alzheimer's disease
Credit: Martin Reuter, Ph.D., and Christian Wachinger, Ph.D., Martinos Center for Biomedical Imaging, Massachusetts General Hospital
MRI data reveals structural asymmetries that vary among individuals, are greater among those who develop dementia
Use of a novel approach to analyzing brain structure that focuses on the shape rather than the size of particular features may allow identification of individuals in early presymptomatic stages of Alzheimer's disease. A team of Massachusetts General Hospital (MGH) investigators using advanced computational tools to analyze data from standard MRI scans report that individuals with Alzheimer's disease, including those diagnosed partway through a multi-year study, had greater levels of asymmetry -- differences in shape between the left and right sides of the brain -- of key brain structures. Their study has been published online in the journal Brain.
Read more »Saturday, October 29, 2016Cardio Stress Response Reduced in Preclinical Alzheimer's
Patients in the earliest stages of Alzheimer's disease show significant decreases in cardiovascular response to stress compared with those who don't have the disease, new research suggests.
Friday, October 28, 2016Researchers Take First Steps Toward A Preventative Alzheimer's Pill: VIDEO
A
preventative Alzheimer’s pill is the ideal end game for researchers
studying the disease from many angles. While we’re not yet close to
the goal, new research shows a way that it may be possible, using an
approach similar to what has worked for managing other chronic
conditions.
Read more »Labels: Video Thursday, October 27, 2016New treatment may reverse Alzheimer's disease: VIDEO
Researchers have created a new drug in the hopes of both preventing and reversing the signs of Alzheimer's disease.
Read more »Labels: Video Wednesday, October 26, 2016Study identifies 2 new genes responsible for Alzheimer's disease among African-Americans
Image Source: USATODAY
Researchers have identified two new genetic risk factors for Alzheimer's disease (AD) among African Americans. Tuesday, October 25, 2016Want to ward off Alzheimer's? Better take your Nuak1: VIDEOCould we fight Alzheimer's with medication the way we fight high cholesterol? New research offers hope(Credit: Siphotography/Depositphotos) Nuak1. It sounds like it could be the name of an android or a distant moon in an upcoming sci-fi film. It is, in fact, an enzyme that recent research shows plays a key role in creating a protein in the brain that contributes to Alzheimer's disease. Manipulating Nuak1 to our advantage could eventually make treating the condition akin to fighting cholesterol with statins, say scientists. Read more » Labels: Video Monday, October 24, 2016Method for Detecting Homemade Bombs Now Targeting Indicator of Dementia
A technique using light intensity to detect explosive residue in homemade bombs, also known as improvised explosive devices (IEDs), is now being used by researchers from the University of Adelaide in South Australia to identify vitamins in blood that are linked to Alzheimer’s disease and dementia.
Read more »Sunday, October 23, 2016New strategy to prevent Alzheimer's disease
Brain section from mouse carrying the dementia-causing P301S mutation in human tau shows accumulation of tau neurofibrillary tangles (in dark brown, left). When Nuak1 levels are decreased by 50 percent (P301S/Nuak1+/-; right), fewer tau tangles accumulate.
Credit: The Zoghbi lab/Baylor College of Medicine
Taking a pill that prevents the accumulation of toxic molecules in the brain might someday help prevent or delay Alzheimer's disease, according to scientists at Baylor College of Medicine, Texas Children's Hospital and Johns Hopkins University School of Medicine.
Read more »Saturday, October 22, 2016Treatment approach used in cancer holds promise for Alzheimer's diseaseImage Source: MEDICALNEWSTODAY Researchers have developed a novel treatment that could block the development of Alzheimer's disease using microscopic droplets of fat to carry drugs into the brain. This treatment approach, which is used to target drugs to cancer cells, has been successfully applied to Alzheimer's disease for the first time, restoring memory loss in mice. Read more » Friday, October 21, 2016Common prostate cancer treatment linked to later dementia, researcher saysMen being treated with prostate cancer therapies that reduce their testosterone levels are at greater risk of developing dementia within five years, a new study shows. Credit: © Michail Petrov / Fotolia A new retrospective study of patient medical records suggests that men with prostate cancer who are treated with testosterone-lowering drugs are twice as likely to develop dementia within five years as prostate cancer patients whose testosterone levels are not tampered with. Read more » Thursday, October 20, 2016Wandering leaves Alzheimer’s patients at risk: VIDEO
It is lunch time at Dana Reynolds’ house. She is busy in the kitchen making a sandwich for her father Henry Cernicek who just moved in August 26.
Read more »Labels: Video Wednesday, October 19, 2016Can this new drug slow the progression of Alzheimer's?Alzheimer's researchers have almost gotten used to having their hopes dashed when a promising drug fails to live up to its potential in clinical trials. But now a new therapy is injecting fresh optimism into the field, and the results are prompting scientists to say it's the best news they've seen for treating this deadly disease in 25 years. Read more » Tuesday, October 18, 2016Alzheimer's Remains a Top Priority for Big PharmaDespite setbacks, Pfizer hasn't lost interest in Alzheimer's disease. Alzheimer's disease (AD) has been a graveyard for experimental medications. A recent study, for instance, reported that a whopping 99.6% of experimental AD drugs failed to improve patient outcomes over the course of 2002 to 2012. Read more » Monday, October 17, 2016How Seth Rogen Is Getting Millennials to Fight Alzheimer’sSeth Rogen and Lauren Miller He founded Hilarity for Charity with his wife, whose mom has early-onset Alzheimer's Some say laughter is the best medicine. Or as iconic comedian/actor/filmmaker Charlie Chaplin put it, “A day without laughter is a day wasted.” Read more » Sunday, October 16, 2016How protein fragments associated with Alzheimer's could trigger Parkinson'sAlzheimer's and Parkinson's diseases are different neurodegenerative conditions that can sometimes affect the same person, which has led scientists to investigate possible links between the two. Now one team, reporting in the journal ACS Chemical Neuroscience, has identified how amyloid beta, the protein fragment strongly associated with Alzheimer's disease, can induce cellular changes that might lead to Parkinson's. Read more » Saturday, October 15, 2016Researchers Create A Gene Therapy Treatment That May Prevent Alzheimer's DiseaseCredit: Wikipedia Alzheimer’s disease is devastating both for those who suffer from it and for those who love them. It is also expensive. It’s estimated that the current worldwide cost of coping with Alzheimer’s is $818 billion. A cure for Alzheimer’s is not available and current treatments for the disease focus on mitigating symptoms rather than eliminating causes. Recent research has provided evidence that the memory loss associated with Alzheimer’s may be preventable and reversible. Now, new research published in the Proceedings of the National Academy of Sciences reports on a gene therapy treatment that stopped the development of Alzheimer’s disease dead in it’s tracks. Read more » Friday, October 14, 2016Online game invites public to help fight Alzheimer's
This file photo taken on March 18, 2011 shows a woman, suffering from Alzheimer's disease, walking in a corridor in a retirement house in Angervilliers, eastern France. For decades now, soaring population growth and ageing rates have been forecast to ignite a global explosion of Alzheimer's, the memory- and freedom-robbing disease afflicting mainly 65-plussers. But an unexpected, and hopeful, trend may be emerging. (AFP/Sastien BOZON)
SAN FRANCISCO, Oct. 5 (Xinhua) -- A new online science game, called Stall Catchers, allows the general public to contribute to Alzheimer's disease research and help researchers search for a cure.
Developed by the Human Computation Institute, in collaboration with the University of California, Berkeley, and other institutions, the game is part of the EyesOnALZ citizen science project that allow participants to look at movies of real blood vessels in mouse brains and search for clogged capillaries, or stalls, where blood is no longer flowing.
Previous research suggests that capillary stalls could be a key culprit in Alzheimer's disease.
Data analysis in Alzheimer's disease research, such as searching for stalls, is a time-consuming task that can cause a single research question to take up to a year to answer in the lab. The EyesOnALZ project aims to accelerate the analysis of these data with the help of citizen scientists playing Stall Catchers so that researchers can find targets for treatment of Alzheimer's faster.
"Today, we have a handful of lab experts putting their eyes on the research data," Pietro Michelucci, principal investigator for EyesOnALZ, was quoted as saying by a news release from UC Berkeley. "If we can enlist thousands of people to do that same analysis by playing an online game, then we have created a huge force multiplier in our fight against this dreadful disease."
The citizen science approach was developed by physicist Andrew Westphal, a senior fellow at the UC Berkeley Space Sciences Laboratory. It was first used in a project called Stardust@home, in which more than 30,000 amateur scientists have carried out more than 100 million searches to identify interstellar dust in collectors returned by the U.S. National Aeronautics and Space Administration (NASA) Stardust comet sampling mission.
Stardust@home led to the discovery of seven particles of likely interstellar origin, reported in the journal Science in 2014.
Referring to Stall Catchers, Westphal said "we are optimistic that this citizen science approach will be similarly successful in accelerating research aimed at finding a cure for Alzheimer's disease."
Story Source: The above story is based on materials provided by NEWCHINA
Note: Materials may be edited for content and length
Thursday, October 13, 2016Researchers Identify Final Step Killing Damaged Neurons in Self-destructive ProcessResearchers have identified the factor at the end of a molecular chain of events killing nerve cells which have been exposed to damage from disease processes such as stroke and possibly Alzheimer’s or a wide variety of other injuries. Read more » Wednesday, October 12, 2016Alzheimer's animal study hints at gene therapy's potential promiseImage Source: SLIDESHARE Gene therapy might one day offer a way to prevent and treat Alzheimer’s disease, new research in mice suggests. Read more » Labels: study Tuesday, October 11, 2016'MIND DIET' SHOWS PROMISE IN REDUCING RISK OF ALZHEIMER'S DISEASE: VIDEODoctors say making food together, eating together as a family and eating a largely plant-based diet is very promising for cutting the risk of Alzheimers disease. (KABC) Many have no doubt heard omega-3 fats in salmon and walnuts are brain boosters, and it's also true of avocados, beets and oats. Read more » Labels: Video Monday, October 10, 2016A Little-Known Drug Company Could Have The Answer For Some Alzheimer's PatientsWhile many rightfully worry about major health issues such as heart disease, cancer and drug resistant infections, the biggest looming crisis could well be Alzheimer’s disease (AD). As baby boomers get older, more and more will suffer from this disease. Yet, other than palliative treatments such as Pfizer’s Aricept (generic name: donepezil) and Allergan’s Namenda (memantine), which only stave off AD for a relatively brief time, there are no drugs available to halt or reverse this crippling disease. Read more » Sunday, October 9, 2016Different brain atrophy patterns may explain variability in Alzheimers disease symptomsCredit: Xiuming Zhang, National University of Singapore Mathematical modeling of the brain scans of patients with Alzheimer's disease and others at risk for the devastating neurodegenerative disorder has identified specific patterns of brain atrophy that appear to be related to the loss of particular cognitive abilities. In their report that has been published online in the Proceedings of the National Academy of Sciences, a team of researchers at Massachusetts General Hospital (MGH) and the National University of Singapore describe how different atrophy patterns may explain the different ways that Alzheimer's disease can be manifested in individual patients. Read more » Saturday, October 8, 2016Protein linked to high risk of Alzheimer's can be removed from brain without hindering learning, memory
New work lends support to the belief that reducing ApoE in the brain could eventually be a viable therapeutic option for treating Alzheimer's.
Credit: © cray7 / Fotolia
A protein linked to higher risk of Alzheimer's can be removed from the brains of mice without hindering memory and learning, according to a study that addresses whether potential therapeutics targeting this protein would have detrimental side effects. Friday, October 7, 2016New online game invites public to help fight Alzheimer’sA screenshot of the Stall Catchers game. Credit: UC Berkeley A new online science game allows the general public to directly contribute to Alzheimer’s disease research and help scientists search for a cure. Read more » Thursday, October 6, 2016Women’s better verbal skills may mask early Alzheimer’s: VIDEO
Women tested better when it came to verbal memory compared to men, even when scans showed similar brain changes, a new study shows. IPGGUTENBERGUKLTD, GETTY IMAGES/ISTOCKPHOTO
Early diagnosis of Alzheimer’s disease in women may be more difficult than in men because older women tend to retain better verbal memory, according to new research.
Read more »Labels: Video Wednesday, October 5, 2016Alzheimer’s is slowly giving up its secrets – and ‘risk genes’ are just one piece of the puzzleAlthough the causes of Alzheimer’s disease remain a mystery, genetic research is now providing clues about how the disease develops. We know that rare genetic mutations can cause early-onset Alzheimer’s, however, both genetic and environmental factors are involved in the more common, late-onset form of the disease. By collecting information on the genetic make-up of thousands of people, scientists in our group, and others, have identified nearly 30 gene variants that are more common in the disease. Read more » Tuesday, October 4, 2016Alzheimer's drug trial failures may be due to second disease40 to 60 percent of Alzheimer's patients may be living with a second dementia-causing disease, a possible explanation for the failure of Alzheimer's drugs in clinical trials. Photo by Kentucky University. The failure of many Alzheimer's disease drug trials can be traced back to patients having a second dementia-causing ailment, Kentucky University scientists say. Read more » Monday, October 3, 2016Genetic score predicts age-related risk of Alzheimer's disease, study says: VIDEOAlzheimer's disease was once unique among illnesses in that a definitive diagnosis could be made only after death. Symptoms of the devastating assault on the brain could be seen from the outside, but those external signs also could be associated with other types of dementia. Read more » Sunday, October 2, 2016Good Clinical Practices Important to Treat Alzheimer’s in People With Down Syndrome
More research is essential to improve protocols for diagnosing Alzheimer’s disease in people with Down syndrome, but the ability to identify and care for those patients is enhanced significantly if clinicians are aware of specific circumstances and use a multi-disciplinary treatment strategy.
Read more »Saturday, October 1, 2016New program helps families with wandering Alzheimer's patientsImage Source: ALZHEIMERSCARERESOURCECENTER A national company with a local branch is launching a free networking system to help families deal with wandering family members suffering from Alzheimer’s disease. Read more » |